Not new therapeutic targets or technology. Bet small portion is fine since any one of them goes to phase III shall increase company's stock cap to $300M. I did not check its cash reserve or partership. The concern is how much cash it will burn for clinic trails.
Not new therapeutic targets or technology. Bet small portion is fine since any one of them goes to phase III shall increase company's stock cap to $300M. I did not check its cash reserve or partership ...
colderdown 发表于 2010-1-8 13:47
Even it true, cycc is years away from drug approval. Put it on radar screen. Unless you are an investor, focus on the biotech plays that are about to complete Phase III drug within 12-16 months.
I see lots of garbage stock flying these days. Perhaps, it is a signal that the end is near.